Steven Garrick is a member of the Interventional Immunology in Early Life Diseases Research group in The Ritchie Centre.
Areas of interest
Bronchopulmonary dysplasia (BPD) COVID-19 Influenza Lupus Necrotising enterocolitis (NEC) Preterm birth
Research group
Interventional Immunology in Early Life Diseases
Steven Garrick
Degree:
PhD student
Research Group:
Research Centre:
Area of study:
Bronchopulmonary dysplasia
Supervisors:
Year of enrolment:
2022
Why did you choose Hudson Institute and your research group?
The Interventional Immunology in Early Life Diseases Laboratory are known for producing high quality and impactful research and have many collaborations. Within our team, basic scientists and clinician scientists work hand in hand to produce highly translatable and clinically relevant research. The prospect of contributing to the research produced by this team was very exciting to me.
What is your research about and what do you hope to achieve?
My PhD investigates the underlying pathophysiology of bronchopulmonary dysplasia (BPD), a chronic lung disease that affects the smallest, lowest gestational age infants. BPD is characterised by interrupted development and injury to the lungs underpinned by inflammation for which there are no safe and effective treatments. Therefore, the goal of my research is to find novel anti-inflammatory strategies to render BPD treatable in early life.
What is it like being a student at Hudson Institute?
Studying at Hudson Institute allows me the opportunity to produce highly translatable research, as we are just next door to Monash Health. I am surrounded by highly experienced scientists across many fields of research, and we have a very supportive student community. I have found it a very rewarding place to study!
